<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF BIOSHIELD TECHNOLOGIES, INC. FOR THE 9 MONTHS ENDED
MARCH 31, 1999 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
       
                             
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          JUN-30-1999
<PERIOD-START>                             JUL-01-1998
<PERIOD-END>                               MAR-31-1999
<CASH>                                       2,868,543
<SECURITIES>                                    91,000
<RECEIVABLES>                                  157,254
<ALLOWANCES>                                    30,000
<INVENTORY>                                    100,350
<CURRENT-ASSETS>                             3,240,721
<PP&E>                                         154,464
<DEPRECIATION>                                  34,123
<TOTAL-ASSETS>                               3,476,512
<CURRENT-LIABILITIES>                          173,198
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     6,480,738
<OTHER-SE>                                  (3,177,424)
<TOTAL-LIABILITY-AND-EQUITY>                 3,476,512
<SALES>                                        286,182
<TOTAL-REVENUES>                               286,182
<CGS>                                          120,726
<TOTAL-COSTS>                                  610,436
<OTHER-EXPENSES>                             1,148,203
<LOSS-PROVISION>                                18,095
<INTEREST-EXPENSE>                              16,960
<INCOME-PRETAX>                             (1,536,020)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                         (1,536,020)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                (1,536,020)
<EPS-PRIMARY>                                    (0.27)<F1>
<EPS-DILUTED>                                        0
<FN>
<F1>DILUTED LOSS PER COMMON SHARE IS NOT DISCLOSED BECAUSE THE EFFECT OF THE
EXCHANGE OR EXERCISE OF COMMON STOCK EQUIVALENTS WOULD BE ANTIDILUTIVE
</FN>